JAC and InterSystems have been presented awards for their work in the European health IT sector, by market analysts Frost and Sullivan.
JAC were awarded The European e-Prescription Systems Technology Innovation award, which was presented to the company for its work throughout the UK.
The award citation states: “The company’s innovative technology, coupled with uncompromising customer support, contribute to JAC’s success in medications management and makes their EPMA [Electronic Prescribing Medications Management] the most trusted e-prescribing solution among the United Kingdom’s hospitals.”
Robert-Tysall-Blay, JAC’s chief executive officer said: “It is very gratifying that the work done over the years in conjunction with our clients has led to the recognition it deserves.”
InterSystems, JAC’s key technology partner, also received an award for European Hospital Information System Customer Leadership Value for demonstrating high levels of customer satisfaction and customer loyalty through its product offering.
Philip Birchall, healthcare business development director, said: “InterSystems is delighted to receive this award as it recognises our commitment to providing market-leading, connected healthcare software supported by a life-long partnership with our healthcare customers to help them meet the continually evolving challenges of this unique market-place.”
The awards, which were held in London, aim to identify the best companies across a range of areas including drug discovery technologies, healthcare and life sciences IT and medical imaging.
Other award winners included Swedish company Anoto, who received the European Care Management Systems Industry Innovation and Advancement Award and Israeli company, Mennen Medical, who were awarded European Patient Monitoring Technology Leadership of the Year Award.
In a keynote speech at the awards, addressing emerging healthcare markets, Sumit Sharma, senior vice president, emerging markets and news business healthcare practice director for Frost and Sullivan said: “As the key healthcare markets begin to saturate and the overall spending by the governments on healthcare is challenged, the need for new markets and growth avenue become more important than ever before.”
Link